Dexchlorpheniramine — Drug Intelligence | 5 EU Trials

Filter these 5 trials by condition, phase, country and more.

5 Registered trials

3 Recruiting

1 Completed trials

4 Sponsors

2 Countries

Phase III

Phase II

Phase I (FiH)

Phase III: 2 Phase II: 2 Phase I (FiH): 1

Sponsors using this IMP

5 total

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post COVID-1… Not authorised

2023-504087-42-00 Phase III 1 country Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocio…
Trial of an investigational drug after the rejection of an allogeneic transplant. Recruiting

2022-503063-15-00 Phase I (FiH) 1 country Fundacion Publica Andaluza para la Gestion de la Investigacion en Salud de Sevil…
Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy Recruiting

2024-513601-31-00 Phase II 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
A multicenter randomized trial to evaluate the efficacy of pioglitazone to improve renal outcome in ANCA-associated vasculitis - RENATO Recruiting

2022-501057-36-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Phase II proof-of-concept, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of plitidepsin in adults w… Ended

2024-516378-31-00 Phase II 1 country Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocio…

Showing 1–5 of 5 trials